olmesartan has been researched along with Cardiovascular Stroke in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, SH; Joo, HJ; Kim, EJ; Kim, JH; Kim, YH; Yum, Y | 1 |
| Chen, M; Jiang, Z; Li, Y; Peng, Y; Shi, S; Song, J | 1 |
| Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M; Zenimura, N | 1 |
| Gelperin, K; Graham, DJ; Hsueh, YH; Levenson, MS; Rose, M; Zhou, EH | 1 |
| Camelo Castillo, W; Delaney, JA; Stürmer, T | 1 |
| Bin, J; Cao, S; Chen, B; Fu, Y; Huang, Q; Huang, X; Kitakaze, M; Liao, Y; Lu, D; Xu, D; Zhang, J | 1 |
| Dai, W; Hale, SL; Jyrala, AJ; Kay, GL; Kloner, RA | 1 |
| Hatanaka, K; Hina, K; Hirohata, A; Hirohata, S; Hirose, E; Ishizawa, M; Kawamura, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, M; Murakami, T; Ohe, T; Ohkawa, K; Sato, S; Yamaji, H; Yamamoto, K; Yamawaki, H | 1 |
| Hamada, J; Kobara, M; Nakata, T; Noda, K; Shiraishi, T; Tanaka, T; Toba, H; Wang, J; Yoshifuji, Y | 1 |
| Kintscher, U | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS | 1 |
| Fischer, JW; Fritzenkötter, C; Li, J; Sandmann, S; Spormann, J; Tiede, K; Unger, T | 1 |
| Aoyama, T; Esaki, M; Fujiwara, H; Kanamori, H; Kawasaki, M; Li, Y; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Okada, H; Takemura, G; Ushikoshi, H | 1 |
1 trial(s) available for olmesartan and Cardiovascular Stroke
| Article | Year |
|---|---|
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Rate; Tetrazoles; Ultrasonography, Interventional | 2010 |
12 other study(ies) available for olmesartan and Cardiovascular Stroke
| Article | Year |
|---|---|
Safety and cardiovascular effectiveness of olmesartan in combination therapy for advanced hypertension: an electronic health record-based cohort study.
Topics: Antihypertensive Agents; Cohort Studies; Electronic Health Records; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Tetrazoles | 2023 |
High-dose nitrate therapy recovers the expression of subtypes α
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors | 2020 |
Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) st
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Imidazoles; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Risk Reduction Behavior; Systole; Tetrazoles | 2018 |
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Risk; Stroke; Tetrazoles | 2014 |
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Imidazoles; Male; Myocardial Infarction; Stroke; Tetrazoles | 2014 |
Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cells, Cultured; Fibroblasts; Growth Differentiation Factor 15; Heart Rupture; Hypoxia; Imidazoles; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Peroxidase; Tetrazoles; Tumor Suppressor Protein p53 | 2014 |
Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Imidazoles; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasodilator Agents; Ventricular Function, Left | 2010 |
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Hemodynamics; Imidazoles; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone; Tetrazoles; Ventricular Function, Left | 2012 |
[Olmesartan after experimental myocardial infarct compared with ramipril: organ protective effect].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Diet, Atherogenic; Drug Evaluation, Preclinical; Imidazoles; Myocardial Infarction; Ramipril; Rats; Tetrazoles | 2005 |
Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Pravastatin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Ventricular Remodeling | 2006 |
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Inflammation; Interleukin-1; Interleukin-6; Male; Myocardial Infarction; Placebos; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; fas Receptor; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Tetrazoles; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |